Pediatric Drug Safety and Medication Use

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 2326

Special Issue Editor


E-Mail Website
Guest Editor
School of Pharmacy, Philadelphia College of Osteopathic Medicine, Suwanee, GA 30024, USA
Interests: pediatrics; obesity; medication use; pharmacy education
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is a known fact that pediatric patients are the most vulnerable to medication errors. Such medication errors may be a result of human or system flaws, and human errors may occur at the stage of medication ordering, medication preparation, compounding of medications for children, or administration of medications. At times, limited clinical data require specialized training and education for the care of pediatric patients. Such errors may lead to harm to the child, potentially even death. The pharmacist plays a critical role in ensuring the safety of medication use in pediatric patients, not only on an individual basis, but also in the systems that provide care for the most vulnerable population.

We invite you to share your experiences, evaluations, innovations, or any service evaluation or research you have undertaken in relation to the role of medication safety in pediatric patients. Various approaches exist for care in a variety of healthcare settings, including acute care, ambulatory care, community practice, and the development of systems or processes in the medication use process. We hope this Special Issue will inspire pharmacists and researchers to share their own practices and adopt new approaches to innovate to improve pediatric drug safety.

Dr. Sandra Benavides
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • medication safety
  • drug errors
  • adverse drug events
  • computerized prescriber order entry
  • comprehensive medication management
  • medication use process
  • drug use errors
  • high-alert drugs

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1442 KiB  
Article
Potential Drug-Related Problems in Pediatric Patients—Describing the Use of a Clinical Decision Support System at Pharmacies in Sweden
by Sazan Abass Abdulkadir, Björn Wettermark and Tora Hammar
Pharmacy 2023, 11(1), 35; https://doi.org/10.3390/pharmacy11010035 - 14 Feb 2023
Viewed by 1834
Abstract
The clinical support system Electronic Expert Support (EES) is available at all pharmacies in Sweden to examine electronic prescriptions when dispensing to prevent drug-related problems (DRPs). DRPs are common, and result in patient suffering and substantial costs for society. The aim of this [...] Read more.
The clinical support system Electronic Expert Support (EES) is available at all pharmacies in Sweden to examine electronic prescriptions when dispensing to prevent drug-related problems (DRPs). DRPs are common, and result in patient suffering and substantial costs for society. The aim of this research was to study the use of EES for the pediatric population (ages 0–12 years), by describing what types of alerts are generated for potential DRPs, how they are handled, and how the use of EES has changed over time. Data on the number and categories of EES analyses, alerts, and resolved alerts were provided by the Swedish eHealth Agency. The study shows that the use of EES has increased. The most common type of alert for a potential DRP among pediatric patients was regarding high doses in children (30.3% of all alerts generated). The most common type of alert for a potential DRP that was resolved among pediatrics was therapy duplication (4.6% of the alerts were resolved). The most common reason for closing an alert was dialogue with patient for verification of the treatment (66.3% of all closed alerts). Knowledge of which type of alerts are the most common may contribute to increased prescriber awareness of important potential DRPs. Full article
(This article belongs to the Special Issue Pediatric Drug Safety and Medication Use)
Show Figures

Figure 1

Back to TopTop